VR
for Cancer Patients
Innovative Technologies for Support and Recovery
Problem
A cancer diagnosis presents not only physical but also severe psychological challenges:
This lowers treatment effectiveness, reduces quality of life, and increases pressure on doctors, psychologists, and families.
Up to 70% of cancer patients experience anxiety and depressive disorders
Pain perception is intensified by stress, worsening the treatment experience
Patients often lose their sense of control, experiencing fear of procedures and uncertainty about the future
Relatives are also prone to emotional burnout and stress
Solution
We offer ready-made and custom VR programs aimed at reducing pain, anxiety, depression, and restoring psychological resilience in cancer patients.
Technologies used:
Pico 4 Pro VR headset
Immersive visual and audio scenarios
Based on mindfulness, cognitive therapy, and resource-based visualization techniques
Unique value proposition:
Use cases:
Benefits for the patient:
Reduced anxiety and pain levels
Lowered fear associated with treatment
Restored sense of control and inner calm
Improved overall quality of life
1.Customizable programs based on age, treatment type, and psychological condition
2.Suitable for use at home or in clinical settings, with no complex setup required
3.Professional support from a team of psycho-oncologists, neuropsychologists, and psychotechnology experts
Preparing patients for surgery, chemotherapy, or radiation therapy
Supporting patients during active treatment
Providing emotional support during remission
Working with the patient’s family and support network
Market
  • Over 4,500 new cancer cases are registered annually in the UAE (2024)
  • Leading clinics such as Burjeel, Mediclinic, Cleveland Clinic Abu Dhabi, and others are actively adopting digital therapy methods, including VR, to support patients and reduce pain and anxiety
  • According to Statista, the VR healthcare market in the UAE is valued at $52 million in 2024, with an average annual growth rate exceeding 28%, projected to reach $235 million by 2030
Target audience:
How We Make Money
Business Model Overview:
  • SaaS (Subscription)
  • B2B licensing
  • Hybrid B2C + B2B
Revenue Growth:
  • CAGR 2020−2024: +32.89%
  • Projected CAGR 2025−2029: up to 45%
  • Three scenarios modeled (20%, 32.89%, 45%)
  • Revenue grows from ~$ 1.3M in 2025 to ~$ 6.3M in 2029
Unit Economics:
  • CAC: TBD (depends on UAE market entry)
  • LTV: high due to long-term subscriptions and B2B retention
  • EBITDA margin: grows from 10% (2025) → 35% (2029)
  • Net profit margin: 8% → 30%
We operate a capital-efficient, high-margin EdTech business with scalable revenue and proven profitability.
Why Invest in X-Technology
➝ 32.89% CAGR (2020–2024)

➝ Active in MENA, Europe, and Asia

➝ B2B SaaS model with white-label flexibility

➝ Under clinical evaluation — scalable solution

➝ Seeking strategic partners for early growth stage

Traction and Experience
Examples of use:
Scientific foundation:
  • VR meditation in palliative care has shown a decrease in patient anxiety (internal project data)

  • A recovery visualization program improved resilience to side effects in patients post-chemotherapy

  • Family VR sessions improved communication between patients and loved ones and reduced burnout among caregivers
  • University of Washington study (Hoffman et al., 2000): VR reduced perceived pain by 30–50% in patients

  • Gorini et al. (2011): Regular VR therapy reduced anxiety by 30–40% in cancer patients
Team
This project was developed by X-Technology specialists in collaboration with clinical psychologists and psychotechnology experts.
Key developers:
Founder of X-Technology, expert in psychotechnology, neuroscience, and VR/AI
  • Over 25 years of experience, educated at Stanford University (USA) and top European institutions
  • Author of the PLPT methodology, developer of educational programs in psychology and coaching
  • Head of the Research Center for Psychotechnologies, actively integrating AI and VR into education and therapy
CTO, AI engineer, product co-developer, specialist in machine learning and VR
  • MSc in Artificial Intelligence and Data Engineering (with distinction) South Ural State University, Russia
  • Developed over 5 AI platforms, including VR headsets with neurofeedback, Telegram bots, and AI avatars
  • Hosted more than 120 events, including scientific conferences
  • Currently pursuing advanced AI studies at Neural University
COO and co-founder of Neumann Academy, Operations Manager at X-Technology
  • Built the company from scratch to $1 million in revenue
  • Leads a team of 32 employees and oversees the LATAM division
  • Program completion rate: 93%, with students earning over 100 million RUB
Nargiza Noimann-Zander
Devid Sidelnikov
Denis Verner
Milestones & Roadmap
Achievements:
MVP (2020–2021): Developed proprietary VR programs and launched the initial learning platform.
Traction (2022–2023): Successfully implemented in clinics and training centers across Russia and CIS; built a user base and received expert endorsements.
Monetization (2023): Launched paid programs, certified training courses, and began commercial sales of VR headsets and services.
Next Steps:
UAE Market Entry (2024–2026): Expand B2B partnerships with hospitals and wellness centers; launch marketing campaigns and local trials.
New Modules: Add programs for oncology support, addiction recovery, and emotional resilience.
New Games: Release gamified therapeutic and educational experiences tailored to local cultures and age groups.
Explore Investment Partnership
Backed by science
Proven in clinics
Built for global growth
Contacts
Email
info@x-technology-uae.com
WhatsApp / Telegram
+971566909609
Trade license
Privacy policy
Phone
0566909609
VR for Clinics
Your VR Kit
For investors